Par Drugs and Chemicals Limited (PAR.NS)

INR 95.99

(1.31%)

Revenue Summary of Par Drugs and Chemicals Limited

  • Par Drugs and Chemicals Limited's latest annual revenue in 2023 was 956.4 Million INR , up 0.57% from previous year.
  • Par Drugs and Chemicals Limited's latest quarterly revenue in 2024 Q2 was 346.56 Million INR , up 53.31% from previous quarter.
  • Par Drugs and Chemicals Limited reported a annual revenue of 950.95 Million INR in annual revenue 2022, up 28.16% from previous year.
  • Par Drugs and Chemicals Limited reported a annual revenue of 742 Million INR in annual revenue 2021, up 23.91% from previous year.
  • Par Drugs and Chemicals Limited reported a quarterly revenue of 346.56 Million INR for 2024 Q2, up 53.31% from previous quarter.
  • Par Drugs and Chemicals Limited reported a quarterly revenue of 258.87 Million INR for 2023 Q2, up 12.87% from previous quarter.

Annual Revenue Chart of Par Drugs and Chemicals Limited (2023 - 2015)

Historical Annual Revenue of Par Drugs and Chemicals Limited (2023 - 2015)

Year Revenue Revenue Growth
2023 956.4 Million INR 0.57%
2022 950.95 Million INR 28.16%
2021 742 Million INR 23.91%
2020 598.8 Million INR 8.68%
2019 550.96 Million INR 20.83%
2018 455.97 Million INR 8.48%
2017 420.34 Million INR -10.03%
2016 467.18 Million INR 40.45%
2015 332.64 Million INR 0.0%

Peer Revenue Comparison of Par Drugs and Chemicals Limited

Name Revenue Revenue Difference
Alembic Pharmaceuticals Limited 61.12 Billion INR 98.435%
Hester Biosciences Limited 3.04 Billion INR 68.596%
Aarti Drugs Limited 25.28 Billion INR 96.218%
Aarti Pharmalabs Limited 18.15 Billion INR 94.732%
Albert David Limited 3.62 Billion INR 73.614%
Alembic Limited 1.57 Billion INR 39.27%
Alkem Laboratories Limited 126.67 Billion INR 99.245%
Bafna Pharmaceuticals Limited 1.52 Billion INR 37.271%
Bajaj HealthCare Limited 4.73 Billion INR 79.798%
Biofil Chemicals and Pharmaceuticals Limited 400.35 Million INR -138.89%
Brooks Laboratories Limited 794.86 Million INR -20.323%
Eris Lifesciences Limited 20.09 Billion INR 95.24%
FDC Limited 19.42 Billion INR 95.078%
Glenmark Life Sciences Limited 22.83 Billion INR 95.811%
Gufic Biosciences Limited 8.06 Billion INR 88.144%
Hikal Limited 17.84 Billion INR 94.641%
Ind-Swift Limited 5.02 Billion INR 80.966%
Innova Captab Limited 10.81 Billion INR 91.155%
IOL Chemicals and Pharmaceuticals Limited 21.32 Billion INR 95.516%
Jagsonpal Pharmaceuticals Limited 2.08 Billion INR 54.174%
Jubilant Pharmova Limited 67.02 Billion INR 98.573%
Lincoln Pharmaceuticals Limited 5.8 Billion INR 83.526%
Lupin Limited 196.56 Billion INR 99.513%
Mangalam Drugs & Organics Limited 3.67 Billion INR 73.965%
Medico Remedies Limited 1.44 Billion INR 34.005%
Morepen Laboratories Limited 17.01 Billion INR 94.38%
Nectar Lifesciences Limited 16.84 Billion INR 94.323%
Orchid Pharma Limited 8.19 Billion INR 88.328%
Procter & Gamble Health Limited 11.51 Billion INR 91.693%
RPG Life Sciences Limited 5.82 Billion INR 83.568%
Kilitch Drugs (India) Limited 1.54 Billion INR 38.046%
Sigachi Industries Limited 3.98 Billion INR 76.027%
Solara Active Pharma Sciences Limited 12.38 Billion INR 92.277%
Suven Pharmaceuticals Limited 10.51 Billion INR 90.903%
Themis Medicare Limited 3.81 Billion INR 74.948%
Unichem Laboratories Limited 16.57 Billion INR 94.23%
Vaishali Pharma Limited 862.79 Million INR -10.849%
Wanbury Limited 5.75 Billion INR 83.386%
Windlas Biotech Limited 6.3 Billion INR 84.842%
ZIM Laboratories Limited 3.67 Billion INR 73.977%
Ind-Swift Laboratories Limited 12.8 Billion INR 92.533%
Ipca Laboratories Limited 77.05 Billion INR 98.759%
Sun Pharmaceutical Industries Limited 484.96 Billion INR 99.803%
Venus Remedies Limited 5.91 Billion INR 83.829%
Sakar Healthcare Limited 1.54 Billion INR 37.963%
Aurobindo Pharma Limited 290.01 Billion INR 99.67%
Divi's Laboratories Limited 78.45 Billion INR 98.781%
AstraZeneca Pharma India Limited 12.95 Billion INR 92.618%
Mankind Pharma Limited 103.34 Billion INR 99.075%
Sequent Scientific Limited 13.69 Billion INR 93.018%
Laurus Labs Limited 50.01 Billion INR 98.088%
Neuland Laboratories Limited 15.58 Billion INR 93.864%
J. B. Chemicals & Pharmaceuticals Limited 34.47 Billion INR 97.226%
Glenmark Pharmaceuticals Limited 118.13 Billion INR 99.19%
Zydus Lifesciences Limited 190.21 Billion INR 99.497%
Amrutanjan Health Care Limited 4.21 Billion INR 77.295%
Wockhardt Limited 27.89 Billion INR 96.571%
Bal Pharma Limited 3.39 Billion INR 71.806%
Dr. Reddy's Laboratories Limited 279.16 Billion INR 99.657%
Bliss GVS Pharma Limited 7.7 Billion INR 87.583%
Caplin Point Laboratories Limited 16.76 Billion INR 94.296%
Shilpa Medicare Limited 11.53 Billion INR 91.706%
Valiant Laboratories Limited 1.82 Billion INR 47.467%
Ajanta Pharma Limited 42.08 Billion INR 97.728%
Aarey Drugs & Pharmaceuticals Limited 3.95 Billion INR 75.825%
Granules India Limited 45.06 Billion INR 97.878%
Medicamen Biotech Limited 1.79 Billion INR 46.661%
Syncom Formulations (India) Limited 2.59 Billion INR 63.108%
Piramal Enterprises Limited 60.33 Billion INR 98.415%
Torrent Pharmaceuticals Limited 106.05 Billion INR 99.098%
NATCO Pharma Limited 40.02 Billion INR 97.61%
Suven Life Sciences Limited 116.92 Million INR -717.936%
Krebs Biochemicals & Industries Limited 504.21 Million INR -89.682%
Strides Pharma Science Limited 40.51 Billion INR 97.639%
Indoco Remedies Limited 18.17 Billion INR 94.737%
Alpa Laboratories Limited 1.08 Billion INR 12.046%
Lasa Supergenerics Limited 1.04 Billion INR 8.333%
Sun Pharma Advanced Research Company Limited 755.45 Million INR -26.6%